News Daily News Meta-analysis: DES Acceptable but Not Trouble-Free for Left Main Disease Caitlin E. Cox August 16, 2012
News Daily News Se Publica el RESET: Eficacia y Seguridad Parecidas con SLE y SLS al cabo de 1 Año L.A. McKeown July 30, 2012
News Daily News RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year L.A. McKeown July 30, 2012
News Conference News EuroPCR 2012 EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage Caitlin E. Cox May 22, 2012
News Conference News EuroPCR 2012 Trials Take on Permanent- vs. Biodegradable-Polymer Technology Caitlin E. Cox May 17, 2012
News Conference News EuroPCR 2012 CIBELES: Xience Stands Up to Cypher for CTO PCI Caitlin E. Cox May 17, 2012
News Conference News EuroPCR 2012 Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations Jason Kahn May 15, 2012
Presentation TCT Russia 2012 Lessons from Pooled Data with Xience Everolimus-Eluting Stents Presenter: Gregg W. Stone April 26, 2012
Presentation ACC 2012 Two-Year Results of the PLATINUM Randomized Trial Comparing Platinum Chromium PROMUS Element and Cobalt Chromium PROMUS/XIENCE V Everolimus-Eluting Stents in De Novo Coronary Artery Lesions Presenter: Gregg Stone March 28, 2012
News Conference News ACC 2012 RESOLUTE: Zotarolimus-Eluting Stent Fares Well at 2 Years March 26, 2012
News Daily News Meta-Analysis: Cobalt-Chromium EES Cut Stent Thrombosis Compared with BMS, Other DES Caitlin E. Cox March 25, 2012
News Daily News Meta-Analysis: Cobalt-Chromium EES Cut Stent Thrombosis Compared with BMS, Other DES Caitlin E. Cox March 25, 2012
News Daily News El SLS es Efectivo contra la Reestenosis tanto Focal como Difusa del SLF March 13, 2012
News Daily News Stent Thrombosis Risk Lower with Xience vs. First-Generation DES Yael L. Maxwell March 06, 2012
News Daily News It’s DESTINY: DES Superior to BMS for Below-the-Knee Lesions Jason Kahn March 06, 2012
News Daily News Ensayo DESTINY: los SLF son Superiores a los SMD en lesiones por debajo de la rodilla Jason Kahn March 06, 2012
News Daily News El Riesgo de Trombosis del Stent es Menor con Xience que con SLF de 1ª Generación Yael L. Maxwell March 06, 2012